Outcome of allogeneic hematopoietic stem cell transplantation for follicular lymphoma relapsing after autologous transplantation: analysis of the Japan Society for …
M Sakurai, T Mori, K Kato, M Kanaya… - Bone Marrow …, 2021 - nature.com
Autologous stem cell transplantation (SCT) is an effective treatment for patients with
relapsed and refractory follicular lymphoma (FL), but more than half patients experience …
relapsed and refractory follicular lymphoma (FL), but more than half patients experience …
[HTML][HTML] High-dose therapy for follicular lymphoma
A Freedman, JW Friedberg, J Gribben - ONCOLOGY-WILLISTON PARK …, 2000 - cgtlive.com
Most patients with advanced-stage follicular non-Hodgkin s lymphoma (NHL) are not cured
with conventional therapy. The use of high-dose therapy and autologous stem-cell …
with conventional therapy. The use of high-dose therapy and autologous stem-cell …
Patterns of outcome following recurrence after myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma
J Apostolidis, JM Foran, PWM Johnson… - Journal of clinical …, 1999 - ascopubs.org
PURPOSE: To assess the patterns of recurrence, management, and survival following
recurrence after myeloablative therapy with autologous bone marrow transplantation …
recurrence after myeloablative therapy with autologous bone marrow transplantation …
High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial
SJ Horning, RS Negrin, RT Hoppe… - Blood, The Journal …, 2001 - ashpublications.org
Advanced stage follicular small cleaved and mixed cell lymphoma is characterized by
relapse from remission and survival ranging from 6 to 12 years. Because young patients …
relapse from remission and survival ranging from 6 to 12 years. Because young patients …
Reduced-intensity rituximab-BEAM-CAMPATH allogeneic haematopoietic stem cell transplantation for follicular lymphoma is feasible and induces durable molecular …
AYL Ho, S Devereux, GJ Mufti, A Pagliuca - Bone marrow …, 2003 - nature.com
The indolent non-Hodgkin's lymphomas are theoretically curable through allogeneic
haematopoietic stem cell transplantation (allo-HSCT). The applicability of standard …
haematopoietic stem cell transplantation (allo-HSCT). The applicability of standard …
[HTML][HTML] Autologous stem cell transplantation for patients with early progression of follicular lymphoma-retrospective analysis of 2 randomized trials of the German low …
V Jurinovic, B Metzner, M Pfreundschuh, N Schmitz… - Blood, 2016 - Elsevier
Background: Follicular lymphoma (FL) is a highly heterogeneous disease. Patients with
early progression of disease (POD) have a remarkably poor outcome. Approximately 20% of …
early progression of disease (POD) have a remarkably poor outcome. Approximately 20% of …
Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine …
IF Khouri, P McLaughlin, RM Saliba… - Blood, The Journal …, 2008 - ashpublications.org
Nonmyeloablative stem cell transplantation in patients with follicular lymphoma has been
designed to exploit the graft-versus-lymphoma immunity. The long-term effectiveness and …
designed to exploit the graft-versus-lymphoma immunity. The long-term effectiveness and …
[HTML][HTML] Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond …
MR Tomblyn, M Ewell, C Bredeson, BS Kahl… - Biology of Blood and …, 2011 - Elsevier
Patients with follicular lymphoma (FL) typically experience an indolent course; however, the
disease is rarely curable with conventional chemotherapy. Autologous hematopoietic cell …
disease is rarely curable with conventional chemotherapy. Autologous hematopoietic cell …
High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: long-term clinical and molecular follow-up
J Apostolidis, RK Gupta, D Grenzelias… - Journal of clinical …, 2000 - ascopubs.org
PURPOSE: To evaluate the long-term results of high-dose therapy (HDT) in follicular
lymphoma, with specific emphasis on the prognostic significance of polymerase chain …
lymphoma, with specific emphasis on the prognostic significance of polymerase chain …
Autologous stem cell transplantation with in vivo purged progenitor cells shows long‐term efficacy in relapsed/refractory follicular lymphoma
High‐dose chemotherapy with autologous stem cell transplantation (ASCT) has been shown
effective in the control of relapsed/refractory follicular lymphoma. We evaluate the long‐term …
effective in the control of relapsed/refractory follicular lymphoma. We evaluate the long‐term …